About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

AONDA Therapeutic Indication Study I | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT05891106

AONDA Therapeutic Indication Study I

This study will be used to support assessment of AIR OPTIX® NIGHT \& DAY® AQUA (AONDA) Soft Contact Lenses' safety and performance in accordance with updated European Union Medical Device Regulation (...

Lead sponsor: Alcon Research•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Alcon Research

In this retrospective observational study, the subject wore AONDA as a therapeutic lens for the treatment of a corneal condition with pain in one or both eyes.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Diagnosis of a corneal condition with pain for which AONDA Soft Contact Lens as a therapeutic contact lens was placed on one or both eye(s) at Baseline.
•Baseline and Follow-up (up to 1 year from Baseline) charts available.

Exclusion Criteria

•Had a condition (pathological, behavioral, and/or situational) that contraindicated therapeutic contact lens wear or confounds study results during the data collection period, as determined or known by the Investigator.
•Used systemic or ocular medication that would confound study results during the data collection period, as determined or known by the Investigator.

Related studies

The Belgian Endothelial Surgical Transplant of the Cornea

NCT05436665 · Corneal Edema, Corneal Endothelial Disorder, and more

RECRUITINGPhase 1

Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty

NCT04319848 · Mild to Moderate Corneal Endothelial Decompensation, Bullous Keratopathy, and more

Endothelial Side Up Inverted Femtosecond Laser Assisted DSAEK

NCT06652321 · Pseudophakic Bullous Keratopathy, Fuchs' Endothelial Dystrophy

Predictive Factors of Graft Detachment Following Dmek

NCT05531760 · Fuchs' Endothelial Corneal Dystrophy, Descemet Membrane Endothelial Keratoplasty, and more

The Effect Of Preoperative Parameters On Success After DMEK Surgery

NCT04420429 · Fuchs' Endothelial Dystrophy, Pseudophakic Bullous Keratopathy, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 20, 2023Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment55

Start dateJun 2023

Last updatedJul 20, 2023

Condition

Bullous Keratopathy Corneal Erosion Entropion Corneal Edema Corneal Dystrophy+6 more

Locations shown

Vision Health Institute

Orlando, Florida

Franklin Park Eye Center PC

Franklin Park, Illinois

Optometry Group, PLLC

Memphis, Tennessee

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 20, 2023Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions